DHR vs MDLN
DHR: A diversified conglomerate applying advanced technologies and quality manufacturing across life sciences, diagnostics, environmental & applied solutions, and industrial products. MDLN: Medline is a global healthcare products and services distributor supplying hospitals, clinics, and other healthcare settings with medical supplies, equipment, and solutions.
Side-by-side fundamentals
| Metric | DHR | MDLN | Edge |
|---|---|---|---|
| Price as of 2026-07-15 close | $200.79 | $39.44 | |
| Market cap as of 2026-07-16 | $142.3B | $51.8B | |
| P/E as of 2026-07-16 | 38.56 | 53.64 | DHR lower |
| PEG as of 2026-07-16 | 3.97 | 11.46 | DHR lower |
| Net margin as of 2026-07-16 | +14.9% | +3.3% | DHR higher |
| Gross margin as of 2026-07-16 | +59.0% | +25.9% | DHR higher |
| Operating margin as of 2026-07-16 | +19.2% | +7.1% | DHR higher |
| ROE as of 2026-07-16 | +7.1% | +6.9% | DHR higher |
| ROA as of 2026-07-16 | +4.5% | +2.6% | DHR higher |
| Debt / equity as of 2026-07-16 | 0.35 | 1.12 | DHR lower |
| Revenue growth (YoY) as of 2026-07-16 | +4.0% | +10.7% | MDLN higher |
| Revenue CAGR (3y) SEC XBRL | -2.7% | +10.6% | MDLN higher |
| Dividend yield as of 2026-07-16 | +0.8% | n/a | |
| Beta as of 2026-07-16 | 0.78 | 1.12 | |
| 1-year return as of 2026-07-15 close | +0.7% | -8.0% | DHR higher |
Fundamentals: Finnhub, as of 2026-07-16. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-15.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.